LAM Research CEO exercises options, sells 30K shares
LAM Research President and CEO Timothy Archer exercised employee stock options and sold shares in an open-market transaction.
Rhea-AI Filing Summary
LAM Research President and CEO Timothy Archer exercised employee stock options and sold shares in an open-market transaction. He exercised options for 30,000 shares of common stock at $30.033 per share and sold 30,000 shares at $390.01 per share on July 2, 2026.
After these transactions, Archer directly owned 1,075,966 shares of LAM Research common stock, with additional indirect holdings in his and his spouse’s 401(k) accounts. The filing notes that the sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on February 24, 2026, and that his reported holdings include shares tied to unvested restricted stock units.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) | 30,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 30,000 | $30.033 | $901K |
| Sale | Common Stock | 30,000 | $390.01 | $11.70M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (3)
- F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2026.
- F2. The amount reported includes shares subject to unvested restricted stock units.
- F3. The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023.
Key Figures
Key Terms
Rule 10b5-1 trading plan financial
restricted stock units financial
Employee Stock Option (Right to Buy) financial
open-market sale financial
FAQ
What insider transaction did LAM Research (LRCX) CEO Timothy Archer report?
What stock options did the LAM Research (LRCX) CEO exercise in this filing?
Do the CEO’s reported LAM Research (LRCX) holdings include restricted stock units?
AI-generated analysis. How Rhea-AI works. Not financial advice.